title: Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment?
authors.affiliation: Unit of PharmacoEpidemiology and PharmacoEconomics (PE), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
authors.forename: Koen B
authors.initials: KB
authors.lastname: Pouwels
authors.forename: Gerard A
authors.initials: GA
authors.lastname: Kalkman
authors.forename: Daan
authors.initials: D
authors.lastname: Schagen
authors.forename: Sipke T
authors.initials: ST
authors.lastname: Visser
authors.forename: Eelko
authors.initials: E
authors.lastname: Hak
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects*; D062313:Databases, Pharmaceutical; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D006801:Humans; D008954:Models, Biological; D010437:Peptic Ulcer / Q000139:chemically induced*; D017891:Pharmacoepidemiology / Q000379:methods; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors